Clinical Trials Browser

OTHER × Carcinoma, Ovarian Epithelial × Surveys and Questionnaires × Clear all

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

NCT02124421 2024-11-19

CRS/HIPEC

Phase 2 Active not recruiting

32 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02530047 2019-07-18

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Phase 1 Completed

5 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01126346 2018-07-03

HOPE

Phase NA Completed

10 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

NCT00813254 2012-04-19

Cost Utility Analysis in Recurrent Ovarian Cancer

Withdrawn

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00596349 2009-02-26

Women Surviving Ovarian Cancer

Completed

62 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial

Clinical Trials

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

CRS/HIPEC

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

HOPE

Cost Utility Analysis in Recurrent Ovarian Cancer

Women Surviving Ovarian Cancer